PEDIATRIX MEDICAL GROUP INC
MDNYSETrading Snapshot
- Day Range
- $25.73 β $26.26
- 52-Week Range
- $15.70 β $27.94
- Volume
- $2.65B
- Avg Volume
- $2.93B
- Shares Outstanding
- 82.1M
- Next Earnings
- Oct 29, 2026
Fundamentals Snapshot
- Annual Revenue
- $1.91B
- Last Q Revenue
- $488M
- P/E Ratio
- 12.3
- P/S Ratio
- 1.1x
- EPS (TTM)
- $2.20
- Dividend Yield
- 0.00%
- Dilution (1yr)
- β1.7%
Why Investors Own MD
- βHigh-growth profile β revenue up +37.4% YoY with expanding US Equity exposure.
- βHealthy economics β 61% gross margin and 7% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
PEDIATRIX MEDICAL GROUP INC
MDAbout PEDIATRIX MEDICAL GROUP INC
Pediatrix Medical Group, Inc. delivers specialized medical services for newborns, expectant mothers, and pediatric patients across the United States and Puerto Rico. The company offers crucial neonatal care to critically ill or prematurely born infants within hospital units, staffed by expert neonatal subspecialists and advanced practice clinicians. For pregnant individuals and their developing babies, Pediatrix provides comprehensive maternal-fetal medicine services in both clinical and inpatient settings, involving specialists such as maternal-fetal medicine physicians, obstetricians, and genetic counselors. Furthermore, the group delivers pediatric cardiology services, addressing both congenital and acquired heart conditions in patients ranging from the fetal stage through adulthood, under the care of dedicated pediatric cardiologists. Beyond these core areas, Pediatrix extends its expertise to various other pediatric subspecialties, including those requiring intensivists, surgeons, and ophthalmologists, and supplies vital support to hospital departments like emergency rooms and labor and delivery units. Established in 1979 in Sunrise, Florida, and formerly known as MEDNAX, Inc. until its renaming in July 2022, the company managed a network of approximately 2,700 physicians as of February 2022.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
PEDIATRIX MEDICAL GROUP INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift MD price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
PEDIATRIX MEDICAL GROUP INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.